Brevinin-2DYb

General Information


DCTPep ID  DCTPep01057

Peptide Name   Brevinin-2DYb

Sequence  GLFDVVKGVLKGAGKNVAGSLLEQLKCKLSGGC

Sequence Length  33

UniProt ID  Not available

PubChem CID  Not available

Origin  Rana dybowskii

Type  Native peptide

Classification

  

ACP Tumor active peptide



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma IC50=23.26 µM MTT assay 24h 1
A549 Lung adenocarcinoma IC50=24.01 µM MTT assay 24h 1
LoVo Colon adenocarcinoma IC50=35.05 µM MTT assay 24h 1
MCF-7 Invasive breast carcinoma of no special type IC50=37.84 µM MTT assay 24h 1

Hemolytic Activity  Sheep erythrocytes: <10% Hemolysis=256 µM

Normal (non-cancerous) Cytotoxicity  HEK293T cells: IC50=50.66 µM

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  DCTPep01057

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys27<--->Cys33

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C145H250N40O42S2

Absent amino acids  HIMPRTWY

Theoretical pI  9.24

Acidic residues  2

Basic residues  5

Polar residues  12

Molecular weight (Average)  3289.94

Molecular weight (Monoisotopic)  3287.81

Common amino acids  G

Net charge  3

Instability index (II)  4.13

Aliphatic index  112.12

Grand average of hydropathicity (GRAVY)  0.397

Half Life 
  30 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 125
  Abs 0.1% (=1 g/l) 0.038, assuming all pairs of Cys residues form cystines
  Ext. coefficient 0
  Abs 0.1% (=1 g/l) 0.000, assuming all Cys residues are reduced

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34073203

Title  Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides

Doi 10.3390/ijms22115630

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.